ASPP1 Antibodies

Santa Cruz Biotechnology provides a broad selection of ASPP1 monoclonal antibodies for research focused on understanding ASPP1 in cellular processes. ASPP1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ASPP1, or Apoptosis-Stimulating Protein of p53, plays a central role in regulating apoptosis and cell survival through p53 signaling pathways. ASPP1 maintains cellular homeostasis and influences cancer development, as changes in ASPP1 expression can affect tumor progression and treatment response. Studying ASPP1 activity reveals key mechanisms of cell death and survival across various diseases. ASPP1 research continues to uncover new insights into cellular regulation and disease mechanisms. ASPP1 investigation advances understanding of cancer biology and potential therapeutic approaches. Ongoing studies of ASPP1 signaling pathways contribute to developments in disease treatment strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of ASPP1 and its impact on human health.